Kidney

In preparation for the 2026 Banff Meeting to be held Oct 5-9, 2026 in Banff, Canada - we are soliciting input from the international transplant community on guiding the discussions at the in-person meeting. Please share your thoughts on the following questions to each of the sessions in your area of interest listed in the blog: (the full program and registration information for the 2026 Banff meeting can be found here: https://site.pheedloop.com/event/2026banffmeeting/schedule)*

*Some final changes to session and presentation titles might occur. 

What are the most important knowledge gaps and/or unmet clinical needs for this session?        

What questions would you ask the moderators and speakers at this session?

Lunch Symposium: Mixed rejection phenotypes: Is it time to Revisit Banff?

Rejection as a spectrum rather than distinct phenotypes

Interstitial inflammation as a key determinant of outcomes in ABMR

Blindspots in the rejection classification

Mixed rejection debate: Do we need a New Banff Category

What are the most important knowledge gaps and/or unmet clinical needs for this session?        

What questions would you ask the moderators and speakers at this session?       

Banff Kidney Concurrent I - Artificial Intelligence, Digital Pathology, and Emerging Spatial Technologies in Clinical Diagnostics

Language models in Pathology and its potential in Transplantation

Pathomics in kidney transplantation and report of the Karman progress

BanffNET development and validation

Results from the DIAGRAF study

Nanopathology - novel frontiers to discover in transplant kidneys

Imaging mass cytometry and potential applications in transplant pathology

Spatial transcriptomics leading to new insights - AMR

Spatial proteomics leading to new insights in MVI and AMR

What are the most important knowledge gaps and/or unmet clinical needs for this session?        

What questions would you ask the moderators and speakers at this session?       

Lunch Symposium # 2 - Time zero biopsies - time to conclude useful or not?

Setting the stage: global practices in the use of implant biopsies

The PITHIA trial: lessons learned?

The Banff Time Zero Biopsies WG – conclusions on the path forward

What are the most important knowledge gaps and/or unmet clinical needs for this session?        

What questions would you ask the moderators and speakers at this session?

Lunch Symposium #3: Activity and chronicity indices to replace the subcategories of active, chronic-active and chronic forms of rejection

Banff WG updates: Pro Con A/C indices

Pathologist's A/C indices "pro" argument; including scope of cases to include

Pathologist's A/C indices "con" argument

Nephrologist's perspective on the potential use and drawbacks of A/C indices

What are the most important knowledge gaps and/or unmet clinical needs for this session?        

What questions would you ask the moderators and speakers at this session?       

Banff Kidney Concurrent II: Updating the Banff Kidney Classification

Unsolved issues remaining after Banff 2022-2024

The v-lesion - important hallmark for rejection classification or innocent bystander?

Polyomavirus nephropathy - time for an updated classification in light of emerging new therapies?

The TCMR classification revisited

AMR/MVI - does the phenotypic spectrum cover reality?

It is not all rejection - what about other causes of inflammation and scarring?

From Mixed Patterns to Diagnostic Prioritization: Identifying Primary and Secondary Processes in Banff

Keeping Banff Globally Relevant: Integrating Innovative and Scalable Tools Across Diverse Resource Settings

Reflections on the evolving Banff framework - Resuscitating the Fossil